Research Paper Volume 14, Issue 13 pp 5590—5610
A pan-cancer analysis confirms PTPN11’s potential as a prognostic and immunological biomarker
Figure 2. Kaplan-Meier analysis of the relationship between PTPN11 expression and survival features of tumors in TCGA. (A) The examination of the link between PTPN11 expression and OS for BLCA, BRCA, CESC, ESCA, KIRC, LUAD, PAAD, READ, THYM, and THCA. (B) The investigation of the association between PTPN11 expression and DFS in CESC, OV, PAAD, and PCPG.